Back to Journals » Drug Design, Development and Therapy » Volume 18

Neurophysiological Characteristics in Type II and Type III 5q Spinal Muscular Atrophy Patients: Impact of Nusinersen Treatment

Total article views   HTML views PDF downloads Totals
1,239 Dovepress* 1,239+ 22 1,261
Totals 1,239 22 1,261
*Since 28 March 2024

View citations on PubMed Central and Google Scholar